Kaitlyn Bader

2 weeks ago | dermatologytimes.com | Raj Chovatiya |Kaitlyn Bader

“Chronic hand eczema can be a tricky diagnosis and a tricky thing to treat, in part because we don't always agree on what the diagnosis is. As long as you've had multiple bouts of eczema on your hands in one year, or a particular symptom of patterns that have been going on for at least 3 months, you really fit the bill for chronic hand eczema,” said Raj Chovatiya, MD, PhD, MSCI, in an interview with Dermatology Times.

2 weeks ago | dermatologytimes.com | Kaitlyn Bader

Recent research by Abraham et al evaluated the response to treatment with dupilumab in patients with hand and facial eczema with simultaneous moderate to severe atopic dermatitis (AD).1 In the poster from the 2025 American Academy of Dermatology Annual Meeting, researchers reviewed data from the TREATgermany prospective multicenter registry for adult patients with moderate to severe AD.

3 weeks ago | dermatologytimes.com | Renata Block |Peter Lio |Kaitlyn Bader

In the first episode of the new Derm Dispatch series, host Renata Block, MMS, PA-C, a board-certified physician assistant in Chicago, Illinois, and a Dermatology Times Editorial Advisory Board member, and guest Peter Lio, MD, a board-certified dermatologist and clinical assistant professor of dermatology and pediatrics at the Northwestern Feinberg School of Medicine in Chicago, Illinois, discuss integrative approaches to managing eczema, including the use of holistic treatments, and how to...

1 month ago | dermatologytimes.com | Kaitlyn Bader

FeatureArticleMarch 14, 2025Author(s):Catch up on all coverage from the 2025 American Academy of Dermatology Annual Meeting held in Orlando, Florida, March 7-11. For all Dermatology Times conference updates and news, subscribe to receive our eNewsletters. The company showcased advancements in tirbanibulin and its early-stage antibody LAD191. Adamson highlights key topics to expect at the AAD Annual Meeting, emphasizing the importance of tackling controversial issues and fostering collaboration.

1 month ago | dermatologytimes.com | Kaitlyn Bader

"We asked both our colleagues in dermatology and patients what comparative effectiveness studies they want done; a lot of them want to see comparative studies of biologics. Interestingly, when we talked to patients, they wanted comparative studies of home phototherapy. Despite all the advances we’ve had in dermatology with biologics, many patients still prefer phototherapy as an effective treatment for psoriasis,” Joel M. Gelfand, MD, MSCE, FAAD, said in a recent interview with Dermatology Times.